Runge V M, Wells J W, Kirsch J E
University of Kentucky, Lexington 40536-0098, USA.
Invest Radiol. 1995 Mar;30(3):135-43. doi: 10.1097/00004424-199503000-00001.
The authors studied the effect of contrast dose, use of magnetization transfer (MT), and temporal delay on the visualization of contrast enhancement with gadoteridol (Gd HP-DO3A) in a canine brain abscess model.
Alpha streptococcus brain abscesses were studied in five dogs at 1.5 tesla (T) 1 and 5 days after implantation. Scans were performed 1, 11, and 21 minutes after contrast was administered, using an initial dose of 0.1 mmol/kg. A supplemental contrast injection of 0.2 mmol/kg was given (for a cumulative dose of 0.3 mmol/kg), with scans repeated at 31, 41, and 51 minutes.
Lesion conspicuity on day 1 was greater at high-contrast doses (0.3 mmol/kg) compared with standard doses (0.1 mmol/kg), regardless of whether imaging was performed without (0.89 +/- 0.02 compared with 0.26 +/- 0.08) or with (0.97 +/- 0.04 compared with 0.28 +/- 0.06) MT. High-dose, MT, and a delay after contrast was injected all produced a statistically significant improvement. On blinded review of films obtained 11 and 14 minutes after injection, enhancement of the lesion could not be identified with certainty in two of five dogs at a dose of 0.1 mmol/kg, regardless of whether MT was used. Enhancement was seen consistently in all lesions at 0.3 mmol/kg. On day 5, results were comparable, with greater absolute enhancement.
In early brain infection, high-contrast doses (0.3 mmol/kg), MT, and a moderate delay after injection all improve visualization of lesion enhancement.
作者在犬脑脓肿模型中研究了对比剂剂量、磁化传递(MT)的使用以及时间延迟对钆特醇(Gd HP-DO3A)增强造影可视化的影响。
对五只犬植入α溶血性链球菌脑脓肿后,于1.5特斯拉(T)场强下,分别在植入后1天和5天进行研究。静脉注射对比剂后,分别于1分钟、11分钟和21分钟进行扫描,初始剂量为0.1 mmol/kg。然后追加注射0.2 mmol/kg对比剂(累计剂量为0.3 mmol/kg),并于31分钟、41分钟和51分钟重复扫描。
在第1天,高对比剂剂量(0.3 mmol/kg)时病变的显影度高于标准剂量(0.1 mmol/kg),无论成像时是否使用MT(未使用MT时为0.89±0.02比0.26±0.08;使用MT时为0.97±0.04比0.28±0.06)。高剂量、MT以及注射对比剂后的延迟均产生了具有统计学意义的改善。在对注射后11分钟和14分钟获得的影像进行盲法评估时,无论是否使用MT,五只犬中有两只在0.1 mmol/kg剂量下无法确定病变是否有强化。在0.3 mmol/kg剂量下,所有病变均可见强化。在第5天,结果类似,绝对强化程度更高。
在早期脑感染中,高对比剂剂量(0.3 mmol/kg)、MT以及注射后适度延迟均能改善病变强化的可视化。